Pulmonary embolism after anti-SARS-CoV-2 vaccines in two female patients.
- Published in:
- Hematology in Clinical Practice, 2023, v. 14, p. 18, doi. 10.5603/HCP.2023.0004
- By:
- Publication type:
- Article
Works matching IS 27201015 AND DT 2023 AND VI 14
Results: 5
1
2
Effective treatment of severe forms of RSV and Pneumocystis jiroveci infections in a child with Down syndrome and acute lymphoblastic leukemia treated with chemotherapy.
- Published in:
- Hematology in Clinical Practice, 2023, v. 14, p. 1, doi. 10.5603/HCP.2023.0001
- By:
- Publication type:
- Article
3
Endocrine-related adverse events associated with targeted treatment and immune checkpoint blockage in hematological malignancies.
- Published in:
- Hematology in Clinical Practice, 2023, v. 14, p. 11, doi. 10.5603/HCP.2023.0003
- By:
- Publication type:
- Article
4
How do I manage the myelotoxicity of venetoclax and azacitidine in patients with newly diagnosed acute myeloid leukemia?
- Published in:
- Hematology in Clinical Practice, 2023, v. 14, p. 6, doi. 10.5603/HCP.2023.0002
- By:
- Publication type:
- Article
5
Study of type and frequency of alfa-thalassemia mutations in a cohort of 3,823 patients from Isfahan Province, Iran.
- Published in:
- Hematology in Clinical Practice, 2023, v. 14, p. 24, doi. 10.5603/HCP.2023.0005
- By:
- Publication type:
- Article